Using published data in Mendelian randomization: A blueprint for efficient identification of causal risk factors

European Journal of Epidemiology

Volumn 30, Issue 7, 2015, Pages 543-552

  Burgess, Stephen ^a   Scott, Robert A ^a   Timpson, Nicholas J ^b   Smith, George Davey ^b   Thompson, Simon G ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Causal inference; Instrumental variable; Mendelian randomization; Published data; Summarized data; Two sample Mendelian randomization

Indexed keywords

CALCIUM; CALCIUM SENSING RECEPTOR; GLUCOSE;

ARTICLE; CALCIUM BLOOD LEVEL; CASR GENE; CAUSAL MODELING; CONFIDENCE INTERVAL; COVARIANCE; DATA ANALYSIS; DIET RESTRICTION; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC RISK; GENETIC VARIABILITY; HUMAN; INSTRUMENTAL VARIABLE ANALYSIS; MENDELIAN RANDOMIZATION ANALYSIS; NORMAL DISTRIBUTION; OUTCOME ASSESSMENT; OUTCOME VARIABLE; PUBLICATION; RECEPTOR GENE; RISK ASSESSMENT; SCORING SYSTEM; STATISTICAL ANALYSIS; VALIDATION PROCESS; GENETIC PREDISPOSITION; PROCEDURES; RANDOMIZATION; RISK FACTOR; SENSITIVITY AND SPECIFICITY;

DATA INTERPRETATION, STATISTICAL; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; HUMANS; MENDELIAN RANDOMIZATION ANALYSIS; RANDOM ALLOCATION; RISK FACTORS; SENSITIVITY AND SPECIFICITY;

EID: 84943354221     PISSN: 03932990     EISSN: 15737284     Source Type: Journal    
DOI: 10.1007/s10654-015-0011-z     Document Type: Article

References (38)

1. Davey Smith G, Ebrahim S. Mendelian randomization: can genetic epidemiology contribute to understanding environmental determinants of disease? Int J Epidemiol. 2003; 32(1): 1-22. doi: 10. 1093/ije/dyg070.
2. Lawlor D, Harbord R, Sterne J, Timpson N, Davey Smith G. Mendelian randomization: using genes as instruments for making causal inferences in epidemiology. Stat Med. 2008; 27(8): 1133-63. doi: 10. 1002/sim. 3034.
3. Didelez V, Sheehan N. Mendelian randomization as an instrumental variable approach to causal inference. Stat Methods Med Res. 2007; 16(4): 309-30. doi: 10. 1177/0962280206077743.
4. Greenland S. An introduction to instrumental variables for epidemiologists. Int J Epidemiol. 2000; 29(4): 722-9. doi: 10. 1093/ije/29. 4. 722.
5. Davey Smith G, Ebrahim S. Mendelian randomization: prospects, potentials, and limitations. Int J Epidemiol. 2004; 33(1): 30-42. doi: 10. 1093/ije/dyh132.
6. Burgess S, Butterworth A, Malarstig A, Thompson S. Use of Mendelian randomisation to assess potential benefit of clinical intervention. Br Med J. 2012; 345: e7325. doi: 10. 1136/bmj. e7325.
7. Kamstrup P, Tybjaerg-Hansen A, Steffensen R, Nordestgaard B. Genetically elevated lipoprotein(a) and increased risk of myocardial infarction. J Am Med Assoc. 2009; 301(22): 2331-9. doi: 10. 1001/jama. 2009. 801.
8. The Interleukin-6 Receptor Mendelian Randomisation Analysis Consortium. The interleukin-6 receptor as a target for prevention of coronary heart disease: a Mendelian randomisation analysis. Lancet. 2012; 379(9822): 1214-1224. doi: 10. 1016/s0140-6736(12)60110-x.
9. Keavney B, Danesh J, Parish S, Palmer A, Clark S, Youngman L, Delepine M, Lathrop M, Peto R, Collins R, et al. Fibrinogen and coronary heart disease: test of causality by 'Mendelian randomization'. Int J Epidemiol. 2006; 35(4): 935-43. doi: 10. 1093/ije/dyl114.
10. CRP CHD Genetics Collaboration. Association between C reactive protein and coronary heart disease: Mendelian randomisation analysis based on individual participant data. Br Med J. 2011; 342: d548. doi: 10. 1136/bmj. d548.
11. Palmer TM, Nordestgaard BG, Benn M, Tybjærg-Hansen A, Smith GD, Lawlor DA, Timpson NJ. Association of plasma uric acid with ischaemic heart disease and blood pressure: Mendelian randomisation analysis of two large cohorts. Br Med J. 2013; 347: f4262. doi: 10. 1136/bmj. f4262.
12. Schatzkin A, Abnet C, Cross A, Gunter M, Pfeiffer R, Gail M, Lim U, Davey Smith G. Mendelian randomization: how it can-and cannot-help confirm causal relations between nutrition and cancer. Cancer Prev Res. 2009; 2(2): 104-13. doi: 10. 1158/1940-6207. capr-08-0070.
13. Schunkert H, König I, Kathiresan S, Reilly M, Assimes T, Holm H, Preuss M, Stewart A, Barbalic M, Gieger C, et al. Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease. Nat Genet. 2011; 43(4): 333-8. doi: 10. 1038/ng. 784.
14. Morris A, Voight B, Teslovich T, Ferreira T, Segre A, Steinthorsdottir V, Strawbridge R, Khan H, Grallert H, Mahajan A, et al. Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes. Nat Genet. 2012; 44(9): 981-90. doi: 10. 1038/ng. 2383.
15. Pierce B, Burgess S. Efficient design for Mendelian randomization studies: subsample and two-sample instrumental variable estimators. Am J Epidemiol. 2013; 178(7): 1177-84. doi: 10. 1093/aje/kwt084.
16. Hindorff L, MacArthur J, Morales J, Junkins H, Hall P, Klemm A, Manolio T. A catalog of published genome-wide association studies. Technical Report, European Bioinformatics Institute 2013. www. genome. gov/gwastudies. Accessed 11 July 2013.
17. Inoue A, Solon G. Two-sample instrumental variables estimators. Rev Econ Stat. 2010; 92(3): 557-61.
18. Hernán M, Robins J. Instruments for causal inference: an epidemiologist's dream? Epidemiology. 2006; 17(4): 360-72. doi: 10. 1097/01. ede. 0000222409. 00878. 37.
19. The International Consortium for Blood Pressure Genome-Wide Association Studies. Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature. 2011; 478: 103-9. doi: 10. 1038/nature10405.
20. Burgess S, Butterworth A, Thompson S. Mendelian randomization analysis with multiple genetic variants using summarized data. Genet Epidemiol. 2013; 37(7): 658-65. doi: 10. 1002/gepi. 21758.
21. Johnson T. Efficient calculation for multi-SNP genetic risk scores. Technical Report, The Comprehensive R Archive Network 2013. http://cran. r-project. org/web/packages/gtx/vignettes/ashg2012. pdf. Accessed 2014/11/19.
22. Baum C, Schaffer M, Stillman S. Instrumental variables and GMM: estimation and testing. Stata J. 2003; 3(1): 1-31.
23. Basmann R. On finite sample distributions of generalized classical linear identifiability test statistics. J Am Stat Assoc. 1960; 55(292): 650-9.
24. Sargan J. The estimation of economic relationships using instrumental variables. Econometrica. 1958; 26(3): 393-415.
25. Hales C, Milner R. Cations and the secretion of insulin from rabbit pancreas in vitro. J Physiol. 1968; 199(1): 177-87.
26. Wareham NJ, Byrne CD, Carr C, Day NE, Boucher BJ, Hales CN. Glucose intolerance is associated with altered calcium homeostasis: a possible link between increased serum calcium concentration and cardiovascular disease mortality. Metabolism. 1997; 46(10): 1171-7. doi: 10. 1016/s0026-0495(97)90212-2.
27. Forouhi N, Ye Z, Rickard A, Khaw K, Luben R, Langenberg C, Wareham N. Circulating 25-hydroxyvitamin D concentration and the risk of type 2 diabetes: results from the European Prospective Investigation into Cancer (EPIC)-Norfolk cohort and updated meta-analysis of prospective studies. Diabetologia. 2012; 55(8): 2173-82. doi: 10. 1007/s00125-012-2544-y.
28. Langenberg C, Sharp S, Forouhi N, Franks P, Schulze M, Kerrison N, Ekelund U, Barroso I, Panico S, Tormo M, et al. Design and cohort description of the InterAct Project: an examination of the interaction of genetic and lifestyle factors on the incidence of type 2 diabetes in the EPIC Study. Diabetologia. 2011; 54(9): 2272-82. doi: 10. 1007/s00125-011-2182-9.
29. Scott RA, Lagou V, Welch RP, Wheeler E, Montasser ME, Luan J, Mägi R, Strawbridge RJ, Rehnberg E, Gustafsson S, et al. Largescale association analyses identify new loci influencing glycemic traits and provide insight into the underlying biological pathways. Nat Genet. 2012; 44(9): 991-1005. doi: 10. 1038/ng. 2385.
30. Kapur K, Johnson T, Beckmann ND, Sehmi J, Tanaka T, Kutalik Z, Styrkarsdottir U, Zhang W, Marek D, Gudbjartsson DF, et al. Genome-wide meta-analysis for serum calcium identifies significantly associated SNPs near the calcium-sensing receptor (CASR) gene. PLoS Genet. 2010; 6(7): e1001035. doi: 10. 1371/journal. pgen. 1001035.
31. O'Seaghdha CM, Yang Q, Glazer NL, Leak TS, Dehghan A, Smith AV, Kao WL, Lohman K, Hwang SJ, Johnson AD, et al. Common variants in the calcium-sensing receptor gene are associated with total serum calcium levels. Hum Mol Genet. 2010; 19(21): 4296-303. doi: 10. 1093/hmg/ddq342.
32. Burgess S, Thompson S. Use of allele scores as instrumental variables for Mendelian randomization. Int J Epidemiol. 2013; 42(4): 1134-44. doi: 10. 1093/ije/dyt093.
33. Yu B, Barbalic M, Brautbar A, Nambi V, Hoogeveen RC, Tang W, Mosley TH, Rotter JI, O'Donnell CJ, Kathiresan S, et al. Association of genome-wide variation with highly sensitive cardiac troponin-T levels in European Americans and Blacks: a meta-analysis from Atherosclerosis Risk in Communities and Cardiovascular Health Studies. Circ Cardiovasc Genet. 2013; 6(1): 82-8. doi: 10. 1161/circgenetics. 112. 963058.
34. Burgess S, Thompson S, CRP CHD genetics collaboration. Avoiding bias from weak instruments in Mendelian randomization studies. Int J Epidemiol. 2011; 40(3): 755-64. doi: 10. 1093/ije/dyr036.
35. Würtz P, Kangas AJ, Soininen P, Lehtimäki T, Kähönen M, Viikari JS, Raitakari OT, Järvelin MR, Davey Smith G, Ala-Korpela M. Lipoprotein subclass profiling reveals pleiotropy in the genetic variants of lipid risk factors for coronary heart disease: a note on Mendelian randomization studies. J Am Coll Cardiol. 2013; 62(20): 1906-8. doi: 10. 1016/j. jacc. 2013. 07. 085.
36. Burgess S, Thompson S. Multivariable Mendelian randomization: the use of pleiotropic genetic variants to estimate causal effects. Am J Epidemiol. 2015; 181(4): 251-60.
37. Burgess S, Thompson S, CRP CHD Genetics Collaboration. Methods for meta-analysis of individual participant data from Mendelian randomization studies with binary outcomes. Stat Methods Med Res. 2012; doi: 10. 1177/0962280212451882.
38. Gidding S, Daniels S, Kavey R. Expert Panel on Cardiovascular Health and Risk Reduction in Youth. Developing the 2011 integrated pediatric guidelines for cardiovascular risk reduction. Pediatrics. 2012; 129(5): e1311-9. doi: 10. 1542/peds. 2011-2903.